Road to 2025: Race on track with clinical trials

Stockhead’s Road to 2025 video series highlights companies’ key 2024 achievements and the routes they’re plotting towards a successful year ahead.

In this episode, Fraser Palamara takes a look at Race Oncology (ASX:RAC), a biopharmaceutical company focusing on addressing the high unmet need of delivering cancer treatments with less cardiotoxicity.

Tune in for a recap of milestones achieved in 2024 and what to look out for in the new year.

This video was developed in collaboration with Race Oncology, a Stockhead advertiser at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.